Moreover, since ErbB2 is also known to play a major role in other cancers, such as ovarian cancer [36, 37], it is possible that nucleolin might be involved in ErbB2 activation in this disease as well, and might affect the progression of this malignancy. The gene discussed is NUCLEOLIN; the disease is ovarian carcinoma.